Finance

Lists
600572:SHA
Zhejiang CONBA Pharmaceutical Co., Ltd.
CN¥4.21
+0.96%
(+0.040) 1D
Oct 30, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600572...
Open
CN¥4.17
High
CN¥4.26
Low
CN¥4.14
Mkt. cap
10.70B
Avg. vol.
40.77M
Volume
48.62M
Dividend
3.56%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
23.66
52-wk high
CN¥5.17
52-wk low
CN¥3.77
EPS
CN¥0.18
Shares outstanding
2.67B
No. of employees
8K
Open
CN¥4.17
High
CN¥4.26
Low
CN¥4.14
Mkt. cap
10.70B
Avg. vol.
40.77M
Volume
48.62M
Dividend
3.56%
Quarterly dividend
CN¥0.04
Ex-dividend date
Jun 24, 2026
P/E ratio
23.66
52-wk high
CN¥5.17
52-wk low
CN¥3.77
EPS
CN¥0.18
Shares outstanding
2.67B
No. of employees
8K
News stories
From web sources and news partners
About Zhejiang CONBA Pharmaceutical Co., Ltd.
CEO-
Employees7.83K
Founded1969
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.50B
1.91B
1.80B
1.63B
Cost of goods sold
751.67M
824.28M
786.71M
725.13M
Cost of revenue
751.67M
824.28M
786.71M
725.13M
Research and development expenses
78.49M
49.23M
62.51M
50.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
611.75M
751.80M
688.94M
630.94M
Operating expense
701.12M
825.90M
777.06M
658.88M
Total operating expenses
1.45B
1.65B
1.56B
1.38B
Operating income
45.06M
255.33M
231.98M
244.69M
Other non operating income
-234.68K
-4.03M
1.79M
-14.45M
EBT including unusual items
-51.57M
249.08M
225.65M
225.46M
EBT excluding unusual items
67.42M
266.37M
255.44M
250.31M
Income tax expense
53.06M
46.05M
40.26M
31.08M
Effective tax rate
-102.87%
18.49%
17.84%
13.78%
Other operating expenses
13.93M
22.15M
21.98M
-16.10M
Net income
-109.67M
198.45M
179.32M
188.64M
Net profit margin
-7.32%
10.41%
9.99%
11.58%
Earnings per share
-
-
-
-
Interest and investment income
26.12M
4.64M
41.65M
12.54M
Interest expense
-1.77M
-1.50M
-528.12K
-
Net interest expenses
24.35M
3.14M
41.13M
12.54M
Depreciation and amortization charges
-
-
-
-
EBITDA
128.05M
338.33M
314.43M
327.69M
Gain or loss from assets sale
-4.89M
-
-522.49K
522.49K
Upcoming events
AI content may include mistakes. Learn more
Google apps